GFACX
Price
$73.35
Change
+$0.38 (+0.52%)
Updated
Nov 19 closing price
Net Assets
327.37B
MLRSX
Price
$13.72
Change
+$0.08 (+0.59%)
Updated
Nov 19 closing price
Net Assets
13.38B
Interact to see
Advertisement

GFACX vs MLRSX

Header iconGFACX vs MLRSX Comparison
Open Charts GFACX vs MLRSXBanner chart's image
American Funds Growth Fund of Amer C
Price$73.35
Change+$0.38 (+0.52%)
VolumeN/A
Net Assets327.37B
NYLI Winslow Large Cap Growth Class R6
Price$13.72
Change+$0.08 (+0.59%)
VolumeN/A
Net Assets13.38B
GFACX vs MLRSX Comparison Chart in %
View a ticker or compare two or three
VS
GFACX vs. MLRSX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Hold and MLRSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 327B vs. MLRSX (13.4B). GFACX (0.00) and MLRSX (0.00) have matching dividends . GFACX was incepted earlier than MLRSX: GFACX (25 years) vs MLRSX (12 years). GFACX (1.36) is less costly to investors than MLRSX (0.63). MLRSX is a more actively managed with annual turnover of: 70.00 vs. GFACX (25.00). MLRSX has a lower initial minimum investment than GFACX: MLRSX (0) vs GFACX (250). GFACX annual gain was more profitable for investors over the last year : 4.83 vs. MLRSX (-3.24). GFACX return over 5 years is better than : 25.13 vs. MLRSX (3.70).
GFACXMLRSXGFACX / MLRSX
Total Expense Ratio1.360.62219%
Annual Report Gross Expense Ratio1.360.63216%
Fund Existence25 years12 years-
Gain YTD15.04113.576111%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets327B13.4B2,440%
Annual Yield % from dividends0.000.00-
Returns for 1 year4.83-3.24-149%
Returns for 3 years55.6740.89136%
Returns for 5 years25.133.70679%
Returns for 10 years70.5421.79324%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CDE14.700.32
+2.23%
Coeur Mining
MBAV10.58N/A
N/A
M3 Brigade Acquisition V Corp.
JANX28.84-0.18
-0.62%
Janux Therapeutics
TLPH1.32-0.02
-1.49%
Talphera
FBIOP6.76-0.14
-2.08%
Fortress Biotech